Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

Soligenix receives grant for acute radiation syndrome therapy

July 18, 2012

Topline results expected early from phase IIb study of vigabatrin

July 16, 2012

BioDelivery Sciences reports on BEMA-buprenorphine/naloxone study

July 4, 2012

Orexo completes dose proportionality study of opioid dependence drug

June 19, 2012

Cleveland BioLabs reports survival results with CBLB-502

June 5, 2012

Phase IIb trial of Catalyst's treatment candidate for cocaine addiction reaches target enrollment

May 22, 2012

NIDA grant supports Scripps Research Institute smoking cessation research

May 16, 2012

Vanda Pharmaceuticals acquires tachykinin NK1 receptor antagonist

April 17, 2012

New vaccine shows promise to treat drug addiction

April 13, 2012

Nippon Shinyaku seeks approval of drug for persons with alcohol dependence

March 27, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...